LEVORPHANOL TARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levorphanol Tartrate, and what generic alternatives are available?
Levorphanol Tartrate is a drug marketed by Hikma, Novitium Pharma, Specgx Llc, Sun Pharm Inds Inc, and Virtus. and is included in five NDAs.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levorphanol Tartrate
A generic version of LEVORPHANOL TARTRATE was approved as levorphanol tartrate by HIKMA on March 31st, 2000.
Summary for LEVORPHANOL TARTRATE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LEVORPHANOL TARTRATE |
DailyMed Link: | LEVORPHANOL TARTRATE at DailyMed |
Pharmacology for LEVORPHANOL TARTRATE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |